[Summary] 细胞治疗服务提供商
作为阿斯利康集团的一员,亘喜生物是一家面向全球、处于临床阶段的生物制药企业,致力于开发创新型细胞疗法。凭借其开创性FasTCAR和TruUCAR技术平台,亘喜生物正在开发丰富的自体和同种异体产品管线,旨在攻克传统CAR-T疗法持续存在的重大行业挑战,包括生产时间长、产品细胞质量欠佳、治疗成本高和对实体瘤与自身免疫性疾病缺乏有效治疗手段等。
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows